Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,042,170
-$72,778 QoQ
Shares Held
37,533
-23.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#266
of 754 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PINEBRIDGE INVESTMENTS LLC holds $185,397,922 across 6 Biotechnology names. EXEL ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
87,050 | $80,762,378 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,709 | $58,914,280 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,819 | $25,243,321 | |
| 4 | INCY |
Incyte Corp
|
107,251 | $12,157,973 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,068 | $6,277,800 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
37,533 | $2,042,170 |
All Filings in EXEL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,042,170 | 37,533 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,114,948 | 49,311 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,977,784 | 45,124 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||